Cencora Inc. Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 9/6/2026)
| Balance Sheet | Total Assets | 76,590,100,000.00 | ROE | 1.97 % |
| Balance Sheet | Total Equity | 1,747,090,000.00 | ROA | 2.03 % |
| Cashflow | Capital Expenditures | -667,981,000.00 | P/FCF | 20.32 |
| Cashflow | Free Cash Flow | 3,207,139,000.00 | – | – |
| Cashflow | Operating Cash Flow | 3,875,120,000.00 | P/CF | 16.82 |
| Income | Earnings per Share (diluted) | 8.02 | Div. Yield | 0.65 % |
| Income | Net Income | 1,554,170,000.00 | P/E | 41.92 |
| Income | Shares Outstanding | 195,214,000.00 | P/B | 43.22 |
| Income | Total Revenue | 321,333,000,000.00 | P/S | 0.20 |
Ratios calculated on: 10/14/2026
Company Description
AmerisourceBergen Corporation (AmerisourceBergenis) is a pharmaceutical services company serving the United States, Canada and select global markets. The Company distributes a range of pharmaceuticalsgeneric pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a range of healthcare providers located in the United States, Canada and selected global markets, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical and dialysis clinics, physicians and physician group practices, long-term care and other alternate site pharmacies, and other customers. In May 2013, the Company completed the divestiture of its contract packaging business, AndersonBrecon. In June 2013, the Company announced that has completed the divestiture of AmerisourceBergen Canada Corporation (ABCC).
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.amerisourcebergen.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more